Subcutaneous Implantable Cardioverter Defibrillator in Patients With Hypertrophic Cardiomyopathy: An Initial Experience
BackgroundThe subcutaneous implantable cardioverter defibrillator (S‐ICD) has been developed to avert risks associated with transvenous defibrillator leads. The technology is attractive for younger patients, such as those with hypertrophic cardiomyopathy (HCM). However, there are limited data on S‐I...
Kaydedildi:
| Asıl Yazarlar: | , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Wiley
2016-02-01
|
| Seri Bilgileri: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
| Konular: | |
| Online Erişim: | https://www.ahajournals.org/doi/10.1161/JAHA.115.002488 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|